Cargando…
Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases: an economic evaluation
INTRODUCTION: Poverty-related and neglected diseases (PRNDs) cause over three million deaths annually. Despite this burden, there is a large gap between actual funding for PRND research and development (R&D) and the funding needed to launch PRND products from the R&D pipeline. This study pro...
Autores principales: | Zimmerman, Armand, Diab, Mohamed Mustafa, Schäferhoff, Marco, McDade, Kaci Kennedy, Yamey, Gavin, Ogbuoji, Osondu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230859/ https://www.ncbi.nlm.nih.gov/pubmed/37247874 http://dx.doi.org/10.1136/bmjgh-2023-011842 |
Ejemplares similares
-
Tracking financing for global common goods for health: A machine learning approach using natural language processing techniques
por: Dixit, Siddharth, et al.
Publicado: (2022) -
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries
por: Schäferhoff, Marco, et al.
Publicado: (2022) -
Strategic donor behaviour and country vulnerability in health aid transitions
por: Mao, Wenhui, et al.
Publicado: (2023) -
Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective
por: McAdams, David, et al.
Publicado: (2020) -
Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19
por: Mao, Wenhui, et al.
Publicado: (2021)